Didn't realize they derive revenue pertaining to boceprevir (http://finance.yahoo.com/news/Codexis-Reports-First-Quarter-prnews-3034608830.html?x=0&.v=1 ). Per those 1Q results, more than $5M in revenue for the quarter came from the boceprevir intermediate.